It's often seen as the final burst of excitement before Lent begins, setting the stage for the solemn preparations leading to Easter Sunday. Carnival Season typically starts after Epiphany on Jan ...

TD Cowen downgraded Merck (MRK) to Hold from Buy with a price target of $100, down from $121. The firm says its Buy thesis “broke down” with Gardasil’s challenges in China. It is ...

TD Cowen initiated coverage of Repligen (RGEN) with a Buy rating and $200 price target Repligen is well positioned for “industry-leading” growth and margin expansion as it is over-indexed ...

In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Amicus (FOLD – Research Report), with a price target of $20.00. The company’s shares closed last Friday at $9.65.

TD Cowen lowered the firm’s price target on Neste (NTOIY) to $8 from $10 and keeps a Hold rating on the shares. The firm previewed its results and expects the company to guide to a flat year ...

In a report released today, Tara Bancroft from TD Cowen maintained a Buy rating on Mersana Therapeutics (MRSN – Research Report). The company’s shares closed last Friday at $0.75. Leverage the ...

TD Cowen analyst Bill Katz raised the firm’s price target on Blue Owl Capital (OWL) to $30 from $28 and keeps a Buy rating on the shares. The firm raised its estimates following Q4 results and ...

TD Cowen lowered the firm’s price target on Avantor (AVTR) to $27 from $28 and keeps a Buy rating on the shares. The firm said while results and guide were a bit mixed, on the whole they portray ...

TD Cowen analyst William Katz maintained a Buy rating on Blue Owl Capital (OWL – Research Report) today and set a price target of $30.00. The company’s shares closed last Friday at $23.56.

On February 6, TD Cowen analyst Krish Sankar maintained a Buy rating on ARM Holdings with a $200 price target, due to strong growth potential. The company exceeded December quarter revenue ...

Investing.com - U.S. President Donald Trump's decision to order the Treasury to cease production of the penny would likely survive judicial review, according to analysts at TD Cowen. On Sunday ...